Ming‐Ming Zhou

26.2k citations
204 papers · 18.4k · 8 hit papers · h-index 65

Impact in

    • Protein Degradation and Inhibitors
    • Epigenetics and DNA Methylation
    • Genomics and Chromatin Dynamics
    • Ubiquitin and proteasome pathways
    • Histone Deacetylase Inhibitors Research
    • Cancer-related gene regulation
    • RNA modifications and cancer
  • Hematology top 0.5%
    • Multiple Myeloma Research and Treatments

Papers in

    • Protein Degradation and Inhibitors 58
    • Ubiquitin and proteasome pathways 29
    • Epigenetics and DNA Methylation 29
    • Genomics and Chromatin Dynamics 28
    • Cancer-related gene regulation 25
    • Histone Deacetylase Inhibitors Research 24
    • Protein Kinase Regulation and GTPase Signaling 16

Ming‐Ming Zhou

197 papers receiving 18.2k citations

Ming‐Ming Zhou's Hit Papers

Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions 2020 · 264 citations
2640+9+18Years since publication4008001.2k

Peers

Ming‐Ming Zhou
Comparison fields: 5 of 177
  • Molecular Biology 13.5k
  • Hematology 1.8k
  • Virology 650
  • Biological Psychiatry 317
  • Cancer Research 1.7k
Replace Hao Wu with:
Hao Wu United States
Adriano Aguzzi Switzerland
Jack P. Antel Canada
Nabil G. Seidah Canada
Edward J. Goetzl United States
Craig J. Thomas United States
Tony Kouzarides United Kingdom
James Davie Canada
Sheldon Milstien United States
Erich Gulbins Germany
Ming‐Ming Zhou relative to Hao Wu United States Hao Wu's profile →
Citations per field
00.5×1.5×2.4×
Hao Wu · 1×
Citations per year

Countries citing papers authored by Ming‐Ming Zhou

Since Specialization
Citations

This map shows the geographic impact of Ming‐Ming Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Ming Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Ming Zhou more than expected).

Fields of papers citing papers by Ming‐Ming Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Ming Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Ming Zhou. The network helps show where Ming‐Ming Zhou may publish in the future.

Co-authors

The 25 scholars most cited alongside Ming‐Ming Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming‐Ming Zhou Line = papers co-authored together Ming‐Ming Zhou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 204 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Structure and ligand of a histone acetyltransferase bromodomain
Hit paper breakdown →
19991347
2
Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a
Hit paper breakdown →
20101127
3
Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior
Hit paper breakdown →
2007671
4
Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice
Hit paper breakdown →
2004648
5
Identification of a serotonin/glutamate receptor complex implicated in psychosis
Hit paper breakdown →
2008628
6
Bromodomain: an acetyl‐lysine binding domain
Hit paper breakdown →
2002584
7
Reading protein modifications with interaction domains
Hit paper breakdown →
2006523
8 2008484
9 2014388
10 2004383
11 2003362
12 2011345
13 2006330
14 1995310
15 2003303
16 2009271
17
Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions
Hit paper breakdown →
2020264
18 2004259
19 2000242
20 2010235

About Ming‐Ming Zhou

Ming‐Ming Zhou is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Hematology and Virology, having authored 204 papers that have together received 18.4k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (58 papers), Ubiquitin and proteasome pathways (29 papers), Epigenetics and DNA Methylation (29 papers), Genomics and Chromatin Dynamics (28 papers), Cancer-related gene regulation (25 papers), Histone Deacetylase Inhibitors Research (24 papers), Protein Kinase Regulation and GTPase Signaling (16 papers) and Multiple Myeloma Research and Treatments (15 papers). The work is most often cited by research in Molecular Biology (13.5k citations), Hematology (1.8k citations), Virology (650 citations), Biological Psychiatry (317 citations) and Cancer Research (1.7k citations). Ming‐Ming Zhou has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Lei Zeng, Roberto Sánchez, Amjad Farooq, Martin J. Walsh, Jay A. Gingrich, Shiraz Mujtaba, Kyoko L. Yap, Alena Lira, Christophe Dhalluin and Aneel K. Aggarwal. Their work appears in journals such as Journal of Biological Chemistry, Structure, Proceedings of the National Academy of Sciences, Molecular Cell and Nature Structural & Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact